Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 29 articles: HTML format

Single Articles

November 2021
1. PLOTKA A, Lewandowski K
   BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
   Acta Haematol. 2021 Nov 24:1-9. doi: 10.1159/000519782.
   PubMed     Abstract available
   
   
   October 2021
2. TAKAHASHI S
   Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy.
   Acta Haematol. 2021 Oct 21:1-9. doi: 10.1159/000519769.
   PubMed     Abstract available
   
   
   September 2021
3. CAI X, Wang J, Lu J, Jia Z, et al
   Adult Acute Myeloid Leukemia with the KMT2A-Mixed Lineage Leukemia T10 Fusion: An Analysis of 10 Cases Showed Common Features and Frequent Mutations in the RAS Signaling Pathway.
   Acta Haematol. 2021 Sep 22:1-7. doi: 10.1159/000518920.
   PubMed     Abstract available
   
   
   
4. YANG S, Zhu R, Li N, Feng Y, et al
   Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation.
   Acta Haematol. 2021 Sep 20:1-9. doi: 10.1159/000518398.
   PubMed     Abstract available
   
   
   
5. MIZRAHI N, Kugler E, Hayman L, Yeshurun M, et al
   T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
   Acta Haematol. 2021 Sep 17:1-5. doi: 10.1159/000519033.
   PubMed     Abstract available
   
   
   June 2021
6. CRISTIANO G, Nanni J, Sartor C, Parisi S, et al
   Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
   Acta Haematol. 2021 Jun 15:1-5. doi: 10.1159/000516003.
   PubMed     Abstract available
   
   
   
7. DANYLESKO I, Canaani J, Shimoni A, Fein J, et al
   Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
   Acta Haematol. 2021 Jun 8:1-7. doi: 10.1159/000515902.
   PubMed     Abstract available
   
   
   April 2021
8. ZHANG X, Liu H, Zheng C, Tang B, et al
   Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
   Acta Haematol. 2021 Apr 13:1-11. doi: 10.1159/000507973.
   PubMed     Abstract available
   
   
   March 2021
9. AITKEN MJL, Benton CB, Issa GC, Sasaki K, et al
   Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.
   Acta Haematol. 2021 Mar 18:1-6. doi: 10.1159/000513925.
   PubMed     Abstract available
   
   
   February 2021
10. LANGERBEINS P, Eichhorst B
    Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
    Acta Haematol. 2021 Feb 25:1-11. doi: 10.1159/000514071.
    PubMed     Abstract available
    
    
    
11. WU B, Mao ZJ, Wang Z, Wu P, et al
    Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine.
    Acta Haematol. 2021 Feb 24:1-8. doi: 10.1159/000513696.
    PubMed     Abstract available
    
    
    January 2021
12. SHAHIN OA, Chifotides HT, Bose P, Masarova L, et al
    Accelerated Phase of Myeloproliferative Neoplasms.
    Acta Haematol. 2021;144:484-499.
    PubMed     Abstract available
    
    
    December 2020
13. HERBORG LL, Nederby L, Brondum RF, Hansen M, et al
    Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.
    Acta Haematol. 2020 Dec 3:1-10. doi: 10.1159/000510504.
    PubMed     Abstract available
    
    
    November 2020
14. SMOLEWSKI P, Robak T
    Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs.
    Acta Haematol. 2020 Nov 25:1-15. doi: 10.1159/000510768.
    PubMed     Abstract available
    
    
    
15. SAMRA B, Kantarjian HM, Sasaki K, Alotaibi AS, et al
    Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant.
    Acta Haematol. 2020 Nov 25:1-8. doi: 10.1159/000510112.
    PubMed     Abstract available
    
    
    
16. TAKAHASHI S
    Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy.
    Acta Haematol. 2020 Nov 20:1-9. doi: 10.1159/000510980.
    PubMed     Abstract available
    
    
    August 2020
17. PATEL SA, Bledsoe JR, Gordon J, Cerny J, et al
    Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche.
    Acta Haematol. 2020 Aug 19:1-5. doi: 10.1159/000508526.
    PubMed     Abstract available
    
    
    June 2020
18. OLSON AL, Saliba RM, Oran B, Chen J, et al
    Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
    Acta Haematol. 2020 Jun 30:1-8. doi: 10.1159/000507012.
    PubMed     Abstract available
    
    
    
19. ALHUMAID MS, Dasouki MJ, Ahmed SO, AbalKhail H, et al
    Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
    Acta Haematol. 2020 Jun 15:1-11. doi: 10.1159/000505715.
    PubMed     Abstract available
    
    
    May 2020
20. ALANAZI W, Chen S, Lipton JH, Kim DD, et al
    Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Acta Haematol. 2020 May 19:1-8. doi: 10.1159/000507536.
    PubMed     Abstract available
    
    
    
21. SELLNER L
    T-Cell Prolymphocytic Leukemia: Long-Term Remissions Challenging!
    Acta Haematol. 2020 May 11:1-2. doi: 10.1159/000507469.
    PubMed    
    
    
    
22. PAUL S, Rausch CR, Jain N, Kadia T, et al
    Treating Leukemia in the Time of COVID-19.
    Acta Haematol. 2020 May 11:1-13. doi: 10.1159/000508199.
    PubMed     Abstract available
    
    
    
23. WAHNSCHAFFE L, Herling M
    What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 May 5:1-3. doi: 10.1159/000507415.
    PubMed    
    
    
    April 2020
24. POH C, Arora M, Ghuman S, Tuscano J, et al
    Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
    Acta Haematol. 2020 Apr 29:1-5. doi: 10.1159/000506918.
    PubMed     Abstract available
    
    
    
25. SHUMILOV E, Hasenkamp J, Szuszies CJ, Koch R, et al
    Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 Apr 7:1-6. doi: 10.1159/000506302.
    PubMed     Abstract available
    
    
    January 2020
26. RAANANI P, Sharf G
    Interview with a Patients' Advocate.
    Acta Haematol. 2020;143:1-4.
    PubMed    
    
    
    
27. KUAN JW, Su AT, Leong CF, Osato M, et al
    Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene.
    Acta Haematol. 2020;143:96-111.
    PubMed     Abstract available
    
    
    
28. BANKAR A, Lipton JH
    Tyrosine Kinase Inhibitors in the Clinical Setting: A Conundrum of Choices.
    Acta Haematol. 2020;143:191-193.
    PubMed    
    
    
    
29. MAITI A, Franquiz MJ, Ravandi F, Cortes JE, et al
    Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
    Acta Haematol. 2020;143:567-573.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: